Tango Therapeutics, Inc. (TNGX) key performance indicators and operating metrics (1 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Collaboration Revenue | 53.8M | FY2025-Q3 |
Back to TNGX overview · TNGX earnings · TNGX holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.